The GALA Trial: Will It Influence Clinical Practice?

Abstract

The General Anesthesia vs. Local Anesthesia for Carotid Surgery (GALA) trial did not show a difference in 30-day postoperative stroke, myocardial infarction and death rates between patients undergoing carotid endarterectomy (CEA) under local vs. general anesthesia. The present article discusses some limitations of the GALA trial. Firstly, the expected stroke and death rates following CEA is so low, that it was unlikely that the GALA trial would show any significant difference between local and general anesthesia. Secondly, preoperative statin use was not recorded. Thirdly, intraoperative shunt usa ge rates (a possible parameter for the development of stroke) varied considerably between the 2 groups (43% vs. 14%, for general vs. local anesthesia, respectively; P < .0001), as well as between UK and non-UK surgeons who always (73.6% vs. 20.8%, respectively; P < .0001), never (4.2% vs. 26%, respectively; P < .0002), or selectively (22.2% vs. 53.2%, respectively; P < .0001) used a shunt. Furthermore, no information was provided regarding the type of shunts used; for example, atraumatic shunts may be associated with lower perioperative stroke rates. These limitations could influence the interpretation of the results of the GALA trial. Due to lack of differences between the 2 groups and the presence of the above limitations, it seems likely that this trial will have little effect on clinical practice.

Keywords

carotid endarterectomy GALA stroke shunts

Get full access to this article

View all access options for this article.

References

GALA Trial Collaborative Group. Lewis SC , Warlow CP , Bodenham AR , et al. General anaesthesia versus local anaesthesia for carotid surgery (GALA): a multicentre, randomised controlled trial. Lancet . 2008;372(9656): 2132-2142.

Paraskevas KI , Mikhailidis DP Anaesthetic techniques for carotid surgery . Lancet. 2009;373(9666):807.

Lewis S. , Gough M. , Bodenham A. , Warlow C. Anaesthetic techniques for carotid surgery-authors’ reply. Lancet. 2009;373(9666):807-808.

McGirt MJ , Perler BA , Brooke BS , et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. J Vasc Surg. 2005;42(5):829-836.

Ridker PM , Danielson E. , Fonseca FA , et al. JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195-2207.

The SPARCL Investigators. Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355(6):549-559.

Sillesen H. , Amarenco P. , Hennerici MG , et al. Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2008;39:3297-3302.

McCleary AJ , Dearden NM , Dickson DH , Watson A. , Gough MJ The differing effects of regional and general anaesthesia on cerebral metabolism during carotid endarterectomy. Eur J Vasc Endovasc Surg. 1996;12(2): 173-181.

Bellosta R. , Luzzani L. , Carugati C. , Talarico M. , Sarcina A. Routine shunting is a safe and reliable method of cerebral protection during carotid endarterectomy. Ann Vasc Surg. 2006 ;20(4):482-487.

10.

Roseborough GS Pro: routine shunting is the optimal management of the patient undergoing carotid endarterectomy. J Cardiothorac Vasc Anesth. 2004;18(3):375-380.

11.

Toronto Cerebrovascular Study Group. Risks of carotid endarterectomy. Stroke. 1986 ;17(5):848-852.

12.

Zampella E. , Morawetz RB , McDowell HA , et al. The importance of cerebral ischemia during carotid endarterectomy. Neurosurgery. 1991;29(5):727-730.

13.

Steiger HJ , Schaffler L. , Boll J. , Liechti S. Results of microsurgical carotid endarterectomy. A prospective study with transcranial Doppler and EEG monitoring, and elective shunting. Acta Neurochir (Wien). 1989; 100(1-2):31-38.

14.

Nguyen TQ , Lind L. , Harris EJ Jr. Selective shunting during carotid endarterectomy. Vascular . 2005;13(1): 23-27.

15.

Halsey JH Jr. Risks and benefits of shunting in carotid endarterectomy. The International Transcranial Doppler Collaborators. Stroke . 1992;23(11):1583-1587.

16.

Bond R. , Rerkasem K. , Counsell C. , et al. Routine or selective carotid artery shunting for carotid endarterectomy (and different methods of monitoring in selective shunting). Cochrane Database Syst Rev. 2002;(2): CD000190.

17.

Woodworth GF , McGirt MJ , Than KD , Huang J. , Perler VA , Tamargo RJ Selective versus routine intraoperative shunting during carotid endarterectomy: a multivariate outcome analysis. Neurosurgery. 2007;61(6): 1170-1176.

18.

Guay J. The GALA trial: answers it gives, answers it does not. Lancet . 2008;372(9656):2092-2093.

19.

Girn HR , Dellagrammaticas D. , Laughlan K. , Gough MJ GALA Trial Collaborators. Carotid endarterectomy: technical practices of surgeons participating in the GALA trial. Eur J Vasc Endovasc Surg . 2008;36(4): 385-389.

20.

Dilaveris P. , Giannopoulos G. , Riga M. , Synetos A. , Stefanadis C. Beneficial effects of statins on endothelial dysfunction and vascular stiffness. Curr Vasc Pharmacol. 2007;5(3):227-237.

21.

Gelosa P. , Cimino M. , Pignieri A. , Tremoli E. , Guerrini U. , Sironi L. The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation . Vasc Health Risk Manag. 2007;3(5):567-577.

22.

Paraskevas KI , Hamilton G. , Mikhailidis DP Statins: an essential component in the management of carotid artery disease. J Vasc Surg. 2007 ;46(2):373-386.